Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
Democratic Party leadership faces criticism over unpopular cultural stances and unclear agenda, as party struggles to define its direction ahead of future elections.
EU fines Delivery Hero and Glovo €329 million for anti-competitive practices in the food delivery market.
Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
Democratic Party leadership faces criticism over unpopular cultural stances and unclear agenda, as party struggles to define its direction ahead of future elections.
EU fines Delivery Hero and Glovo €329 million for anti-competitive practices in the food delivery market.